US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 85.310
  • -0.720-0.84%
Close Dec 3 16:00 ET
  • 87.840
  • +2.530+2.97%
Post 17:50 ET
9.04BMarket Cap-98057P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
104.16%1.01B
99.45%1.02B
-11.71%475.62M
-15.87%497.94M
-15.87%497.94M
-21.59%493.02M
-24.34%512.85M
-30.21%538.71M
43.55%591.91M
43.55%591.91M
-Cash and cash equivalents
367.11%464.31M
387.36%693.31M
84.64%139.82M
-0.57%147.77M
-0.57%147.77M
-26.56%99.4M
84.19%142.26M
-41.43%75.73M
60.90%148.62M
60.90%148.62M
-Short-term investments
37.76%542.25M
-11.06%329.6M
-27.47%335.8M
-21.01%350.17M
-21.01%350.17M
-20.22%393.62M
-38.30%370.6M
-27.95%462.98M
38.54%443.29M
38.54%443.29M
Receivables
41.82%145.61M
51.84%145.71M
60.84%131.16M
51.64%114.02M
51.64%114.02M
66.84%102.67M
104.28%95.96M
148.37%81.55M
273.04%75.19M
273.04%75.19M
-Accounts receivable
41.82%145.61M
51.84%145.71M
60.84%131.16M
51.64%114.02M
51.64%114.02M
66.84%102.67M
104.28%95.96M
148.37%81.55M
273.04%75.19M
273.04%75.19M
Inventory
-45.24%23.54M
-52.07%20.08M
-43.72%15.95M
-51.31%11.65M
-51.31%11.65M
82.17%42.99M
67.43%41.9M
259.06%28.34M
200.96%23.92M
200.96%23.92M
Restricted cash
0.00%1.75M
0.00%1.75M
0.00%1.75M
0.00%1.75M
0.00%1.75M
0.00%1.75M
25.00%1.75M
25.00%1.75M
25.00%1.75M
25.00%1.75M
Other current assets
52.06%94.27M
61.80%73.8M
18.47%66.05M
-6.09%42.44M
-6.09%42.44M
40.49%62M
20.09%45.61M
62.21%55.75M
77.62%45.19M
77.62%45.19M
Total current assets
81.05%1.27B
81.11%1.26B
-2.20%690.53M
-9.51%667.8M
-9.51%667.8M
-7.55%702.43M
-11.55%698.07M
-16.77%706.09M
57.93%737.96M
57.93%737.96M
Non current assets
Net PPE
5.70%16.02M
3.30%15.95M
-12.36%14M
-12.88%14.58M
-12.88%14.58M
-31.61%15.15M
-31.71%15.44M
-20.71%15.98M
-25.79%16.74M
-25.79%16.74M
-Gross PPE
5.70%16.02M
3.30%15.95M
-12.36%14M
-12.88%14.58M
-12.88%14.58M
-31.61%15.15M
-31.71%15.44M
-20.71%15.98M
-38.29%16.74M
-38.29%16.74M
Other non current assets
42,572.09%36.7M
46,761.63%40.3M
49,325.58%42.51M
53,288.37%45.91M
53,288.37%45.91M
0.00%86K
0.00%86K
0.00%86K
0.00%86K
0.00%86K
Total non current assets
245.92%52.71M
262.24%56.25M
251.77%56.51M
259.60%60.5M
259.60%60.5M
-31.49%15.24M
-31.59%15.53M
-20.62%16.06M
-25.70%16.82M
-25.70%16.82M
Total assets
84.55%1.32B
85.05%1.32B
3.44%747.04M
-3.51%728.3M
-3.51%728.3M
-8.23%717.66M
-12.11%713.6M
-16.86%722.16M
54.06%754.78M
54.06%754.78M
Liabilities
Current liabilities
Payables
-2.59%10.34M
126.92%17.55M
36.62%11.53M
10.17%11.45M
10.17%11.45M
-25.36%10.61M
-28.06%7.73M
-27.54%8.44M
19.61%10.4M
19.61%10.4M
-accounts payable
-2.59%10.34M
126.92%17.55M
36.62%11.53M
10.17%11.45M
10.17%11.45M
-25.36%10.61M
-28.06%7.73M
-27.54%8.44M
19.61%10.4M
19.61%10.4M
Current accrued expenses
92.41%122.08M
98.90%117.68M
102.56%103.22M
79.15%81.12M
79.15%81.12M
82.34%63.45M
75.27%59.17M
120.16%50.96M
165.76%45.28M
165.76%45.28M
Current debt and capital lease obligation
17.27%4.2M
17.23%4.17M
3.06%3.64M
-20.91%3.61M
-20.91%3.61M
-50.53%3.58M
-54.05%3.56M
-53.76%3.53M
-32.16%4.57M
-32.16%4.57M
-Current capital lease obligation
17.27%4.2M
17.23%4.17M
3.06%3.64M
-20.91%3.61M
-20.91%3.61M
-50.53%3.58M
-54.05%3.56M
-53.76%3.53M
-32.16%4.57M
-32.16%4.57M
Current liabilities
61.13%166.11M
75.69%161.78M
69.38%134.8M
48.43%123.55M
48.43%123.55M
33.18%103.09M
30.36%92.08M
34.72%79.59M
56.00%83.24M
56.00%83.24M
Non current liabilities
Long term debt and capital lease obligation
-2.77%13.51M
-2.18%14.12M
-14.87%12.74M
-13.88%13.33M
-13.88%13.33M
-27.53%13.89M
-24.34%14.43M
-10.71%14.96M
-17.14%15.47M
-17.14%15.47M
-Long term capital lease obligation
-2.77%13.51M
-2.18%14.12M
-14.87%12.74M
-13.88%13.33M
-13.88%13.33M
-27.53%13.89M
-24.34%14.43M
-10.71%14.96M
-17.14%15.47M
-17.14%15.47M
Total non current liabilities
-2.77%13.51M
-2.18%14.12M
-14.87%12.74M
-13.88%13.33M
-13.88%13.33M
-27.53%13.89M
-24.34%14.43M
-10.71%14.96M
-17.14%15.47M
-17.14%15.47M
Total liabilities
53.54%179.62M
65.14%175.89M
56.05%147.54M
38.66%136.87M
38.66%136.87M
21.13%116.98M
18.73%106.51M
24.68%94.55M
37.04%98.71M
37.04%98.71M
Shareholders'equity
Share capital
10.00%11K
10.00%11K
0.00%10K
11.11%10K
11.11%10K
11.11%10K
11.11%10K
11.11%10K
12.50%9K
12.50%9K
-common stock
10.00%11K
10.00%11K
0.00%10K
11.11%10K
11.11%10K
11.11%10K
11.11%10K
11.11%10K
12.50%9K
12.50%9K
Retained earnings
-5.44%-1.67B
-5.39%-1.65B
-7.29%-1.63B
-9.45%-1.62B
-9.45%-1.62B
-10.82%-1.59B
-13.36%-1.56B
-17.64%-1.52B
-20.98%-1.48B
-20.98%-1.48B
Paid-in capital
28.65%2.82B
28.53%2.79B
3.74%2.23B
3.31%2.21B
3.31%2.21B
3.12%2.19B
3.17%2.17B
2.99%2.15B
30.39%2.14B
30.39%2.14B
Gains losses not affecting retained earnings
222.02%1.63M
70.55%-668K
84.06%-430K
102.48%104K
102.48%104K
75.71%-1.34M
52.77%-2.27M
18.93%-2.7M
-1,051.10%-4.19M
-1,051.10%-4.19M
Total stockholders'equity
90.59%1.14B
88.54%1.14B
-4.48%599.5M
-9.85%591.42M
-9.85%591.42M
-12.36%600.68M
-15.94%607.09M
-20.83%627.61M
57.00%656.07M
57.00%656.07M
Total equity
90.59%1.14B
88.54%1.14B
-4.48%599.5M
-9.85%591.42M
-9.85%591.42M
-12.36%600.68M
-15.94%607.09M
-20.83%627.61M
57.00%656.07M
57.00%656.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 104.16%1.01B99.45%1.02B-11.71%475.62M-15.87%497.94M-15.87%497.94M-21.59%493.02M-24.34%512.85M-30.21%538.71M43.55%591.91M43.55%591.91M
-Cash and cash equivalents 367.11%464.31M387.36%693.31M84.64%139.82M-0.57%147.77M-0.57%147.77M-26.56%99.4M84.19%142.26M-41.43%75.73M60.90%148.62M60.90%148.62M
-Short-term investments 37.76%542.25M-11.06%329.6M-27.47%335.8M-21.01%350.17M-21.01%350.17M-20.22%393.62M-38.30%370.6M-27.95%462.98M38.54%443.29M38.54%443.29M
Receivables 41.82%145.61M51.84%145.71M60.84%131.16M51.64%114.02M51.64%114.02M66.84%102.67M104.28%95.96M148.37%81.55M273.04%75.19M273.04%75.19M
-Accounts receivable 41.82%145.61M51.84%145.71M60.84%131.16M51.64%114.02M51.64%114.02M66.84%102.67M104.28%95.96M148.37%81.55M273.04%75.19M273.04%75.19M
Inventory -45.24%23.54M-52.07%20.08M-43.72%15.95M-51.31%11.65M-51.31%11.65M82.17%42.99M67.43%41.9M259.06%28.34M200.96%23.92M200.96%23.92M
Restricted cash 0.00%1.75M0.00%1.75M0.00%1.75M0.00%1.75M0.00%1.75M0.00%1.75M25.00%1.75M25.00%1.75M25.00%1.75M25.00%1.75M
Other current assets 52.06%94.27M61.80%73.8M18.47%66.05M-6.09%42.44M-6.09%42.44M40.49%62M20.09%45.61M62.21%55.75M77.62%45.19M77.62%45.19M
Total current assets 81.05%1.27B81.11%1.26B-2.20%690.53M-9.51%667.8M-9.51%667.8M-7.55%702.43M-11.55%698.07M-16.77%706.09M57.93%737.96M57.93%737.96M
Non current assets
Net PPE 5.70%16.02M3.30%15.95M-12.36%14M-12.88%14.58M-12.88%14.58M-31.61%15.15M-31.71%15.44M-20.71%15.98M-25.79%16.74M-25.79%16.74M
-Gross PPE 5.70%16.02M3.30%15.95M-12.36%14M-12.88%14.58M-12.88%14.58M-31.61%15.15M-31.71%15.44M-20.71%15.98M-38.29%16.74M-38.29%16.74M
Other non current assets 42,572.09%36.7M46,761.63%40.3M49,325.58%42.51M53,288.37%45.91M53,288.37%45.91M0.00%86K0.00%86K0.00%86K0.00%86K0.00%86K
Total non current assets 245.92%52.71M262.24%56.25M251.77%56.51M259.60%60.5M259.60%60.5M-31.49%15.24M-31.59%15.53M-20.62%16.06M-25.70%16.82M-25.70%16.82M
Total assets 84.55%1.32B85.05%1.32B3.44%747.04M-3.51%728.3M-3.51%728.3M-8.23%717.66M-12.11%713.6M-16.86%722.16M54.06%754.78M54.06%754.78M
Liabilities
Current liabilities
Payables -2.59%10.34M126.92%17.55M36.62%11.53M10.17%11.45M10.17%11.45M-25.36%10.61M-28.06%7.73M-27.54%8.44M19.61%10.4M19.61%10.4M
-accounts payable -2.59%10.34M126.92%17.55M36.62%11.53M10.17%11.45M10.17%11.45M-25.36%10.61M-28.06%7.73M-27.54%8.44M19.61%10.4M19.61%10.4M
Current accrued expenses 92.41%122.08M98.90%117.68M102.56%103.22M79.15%81.12M79.15%81.12M82.34%63.45M75.27%59.17M120.16%50.96M165.76%45.28M165.76%45.28M
Current debt and capital lease obligation 17.27%4.2M17.23%4.17M3.06%3.64M-20.91%3.61M-20.91%3.61M-50.53%3.58M-54.05%3.56M-53.76%3.53M-32.16%4.57M-32.16%4.57M
-Current capital lease obligation 17.27%4.2M17.23%4.17M3.06%3.64M-20.91%3.61M-20.91%3.61M-50.53%3.58M-54.05%3.56M-53.76%3.53M-32.16%4.57M-32.16%4.57M
Current liabilities 61.13%166.11M75.69%161.78M69.38%134.8M48.43%123.55M48.43%123.55M33.18%103.09M30.36%92.08M34.72%79.59M56.00%83.24M56.00%83.24M
Non current liabilities
Long term debt and capital lease obligation -2.77%13.51M-2.18%14.12M-14.87%12.74M-13.88%13.33M-13.88%13.33M-27.53%13.89M-24.34%14.43M-10.71%14.96M-17.14%15.47M-17.14%15.47M
-Long term capital lease obligation -2.77%13.51M-2.18%14.12M-14.87%12.74M-13.88%13.33M-13.88%13.33M-27.53%13.89M-24.34%14.43M-10.71%14.96M-17.14%15.47M-17.14%15.47M
Total non current liabilities -2.77%13.51M-2.18%14.12M-14.87%12.74M-13.88%13.33M-13.88%13.33M-27.53%13.89M-24.34%14.43M-10.71%14.96M-17.14%15.47M-17.14%15.47M
Total liabilities 53.54%179.62M65.14%175.89M56.05%147.54M38.66%136.87M38.66%136.87M21.13%116.98M18.73%106.51M24.68%94.55M37.04%98.71M37.04%98.71M
Shareholders'equity
Share capital 10.00%11K10.00%11K0.00%10K11.11%10K11.11%10K11.11%10K11.11%10K11.11%10K12.50%9K12.50%9K
-common stock 10.00%11K10.00%11K0.00%10K11.11%10K11.11%10K11.11%10K11.11%10K11.11%10K12.50%9K12.50%9K
Retained earnings -5.44%-1.67B-5.39%-1.65B-7.29%-1.63B-9.45%-1.62B-9.45%-1.62B-10.82%-1.59B-13.36%-1.56B-17.64%-1.52B-20.98%-1.48B-20.98%-1.48B
Paid-in capital 28.65%2.82B28.53%2.79B3.74%2.23B3.31%2.21B3.31%2.21B3.12%2.19B3.17%2.17B2.99%2.15B30.39%2.14B30.39%2.14B
Gains losses not affecting retained earnings 222.02%1.63M70.55%-668K84.06%-430K102.48%104K102.48%104K75.71%-1.34M52.77%-2.27M18.93%-2.7M-1,051.10%-4.19M-1,051.10%-4.19M
Total stockholders'equity 90.59%1.14B88.54%1.14B-4.48%599.5M-9.85%591.42M-9.85%591.42M-12.36%600.68M-15.94%607.09M-20.83%627.61M57.00%656.07M57.00%656.07M
Total equity 90.59%1.14B88.54%1.14B-4.48%599.5M-9.85%591.42M-9.85%591.42M-12.36%600.68M-15.94%607.09M-20.83%627.61M57.00%656.07M57.00%656.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+3.51%
Coinbase
COIN
+2.30%
Amazon
AMZN
+1.30%
Apple
AAPL
+1.28%
Oracle
ORCL
+0.82%

Unlock the Full List